Darunavir · more major-labeled pairs than Buprenorphine/Naloxone

SPL labels Buprenorphine/Naloxone + Darunavir as minor; Buprenorphine/Naloxone 19 / Darunavir 70 in that band.

Mechanism on file: Darunavir causes your body to produce more of a specific byproduct from buprenorphine and naloxone.

FDA SPL severity: Minor

Buprenorphine/Naloxone

Full Buprenorphine/Naloxone label record

Partial Opioid Agonist / Antagonist

Darunavir

Full Darunavir label record

HIV Protease Inhibitor

Buprenorphine/Naloxone + Darunavir · SPL mechanism field

Darunavir causes your body to produce more of a specific byproduct from buprenorphine and naloxone.

Minor band excerpt · Buprenorphine/Naloxone with Darunavir

Narcotic analgesics/treatment of opioid dependence : buprenorphine, buprenorphine/naloxone ↔ buprenorphine, naloxone ↑ norbuprenorphine (metabolite) No dose adjustment for buprenorphine or buprenorphine/naloxone is required with concurrent administration of darunavir/ritonavir. Clinical monitoring is recommended if darunavir/ritonavir and buprenorphine or buprenorphine/naloxone are co-administered.

Darunavir · 15 major-labeled pairs (vs Buprenorphine/Naloxone's 0)

View all Darunavir interactions →

FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.